Johnson & Johnson, a global healthcare leader, relies on Altair’s high-performance computing (HPC) solutions to accelerate pharmaceutical development, including work by its Janssen Pharmaceuticals division. Altair’s technology powers critical drug discovery and production efforts, enabling efficient research and innovation such as the development of the one-dose COVID-19 vaccine. By leveraging Altair’s HPC capabilities, Johnson & Johnson enhances its ability to deliver effective, widely accessible medicines that benefit billions worldwide, supporting its mission to improve global health through cutting-edge science.

Join for free to read